nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CYP3A4—Everolimus—kidney cancer	0.0656	0.0958	CbGbCtD
Primidone—CYP2C8—Pazopanib—kidney cancer	0.0574	0.0838	CbGbCtD
Primidone—CYP1A2—Pazopanib—kidney cancer	0.0444	0.0649	CbGbCtD
Primidone—CYP3A4—Temsirolimus—kidney cancer	0.0443	0.0647	CbGbCtD
Primidone—CYP2B6—Sorafenib—kidney cancer	0.044	0.0642	CbGbCtD
Primidone—CYP2C9—Capecitabine—kidney cancer	0.0417	0.061	CbGbCtD
Primidone—CYP2C8—Erlotinib—kidney cancer	0.0409	0.0598	CbGbCtD
Primidone—CYP2C8—Paclitaxel—kidney cancer	0.0375	0.0547	CbGbCtD
Primidone—CYP2C8—Sorafenib—kidney cancer	0.0333	0.0486	CbGbCtD
Primidone—CYP1A2—Erlotinib—kidney cancer	0.0317	0.0463	CbGbCtD
Primidone—CYP2C19—Sorafenib—kidney cancer	0.0279	0.0408	CbGbCtD
Primidone—CYP2B6—Doxorubicin—kidney cancer	0.0267	0.039	CbGbCtD
Primidone—CYP2C9—Paclitaxel—kidney cancer	0.0261	0.0382	CbGbCtD
Primidone—CYP1A2—Sorafenib—kidney cancer	0.0258	0.0376	CbGbCtD
Primidone—CYP3A4—Pazopanib—kidney cancer	0.0233	0.034	CbGbCtD
Primidone—CYP2C9—Sorafenib—kidney cancer	0.0232	0.0339	CbGbCtD
Primidone—CYP3A4—Erlotinib—kidney cancer	0.0166	0.0243	CbGbCtD
Primidone—CYP3A4—Paclitaxel—kidney cancer	0.0152	0.0222	CbGbCtD
Primidone—CYP3A4—Sorafenib—kidney cancer	0.0135	0.0197	CbGbCtD
Primidone—CYP3A4—Vinblastine—kidney cancer	0.0133	0.0195	CbGbCtD
Primidone—CYP3A4—Vincristine—kidney cancer	0.0131	0.0191	CbGbCtD
Primidone—CYP3A4—Sunitinib—kidney cancer	0.0109	0.016	CbGbCtD
Primidone—CYP3A4—Doxorubicin—kidney cancer	0.00819	0.012	CbGbCtD
Primidone—Depression—Sunitinib—kidney cancer	0.00121	0.00512	CcSEcCtD
Primidone—Skin disorder—Temsirolimus—kidney cancer	0.00121	0.00512	CcSEcCtD
Primidone—Anorexia—Temsirolimus—kidney cancer	0.00118	0.00502	CcSEcCtD
Primidone—Eye disorder—Erlotinib—kidney cancer	0.00117	0.00497	CcSEcCtD
Primidone—Nervous system disorder—Pazopanib—kidney cancer	0.00115	0.00487	CcSEcCtD
Primidone—Mental disorder—Everolimus—kidney cancer	0.00114	0.00483	CcSEcCtD
Primidone—Skin disorder—Pazopanib—kidney cancer	0.00114	0.00482	CcSEcCtD
Primidone—Malnutrition—Everolimus—kidney cancer	0.00113	0.0048	CcSEcCtD
Primidone—Musculoskeletal discomfort—Temsirolimus—kidney cancer	0.00113	0.0048	CcSEcCtD
Primidone—Anorexia—Pazopanib—kidney cancer	0.00112	0.00473	CcSEcCtD
Primidone—Visual disturbance—Paclitaxel—kidney cancer	0.00111	0.00472	CcSEcCtD
Primidone—Connective tissue disorder—Sorafenib—kidney cancer	0.00111	0.0047	CcSEcCtD
Primidone—Somnolence—Temsirolimus—kidney cancer	0.00111	0.00468	CcSEcCtD
Primidone—Mental disorder—Erlotinib—kidney cancer	0.0011	0.00466	CcSEcCtD
Primidone—Malnutrition—Erlotinib—kidney cancer	0.00109	0.00463	CcSEcCtD
Primidone—Decreased appetite—Temsirolimus—kidney cancer	0.00108	0.00458	CcSEcCtD
Primidone—Nystagmus—Doxorubicin—kidney cancer	0.00108	0.00456	CcSEcCtD
Primidone—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00107	0.00455	CcSEcCtD
Primidone—Fatigue—Temsirolimus—kidney cancer	0.00107	0.00454	CcSEcCtD
Primidone—Agranulocytosis—Dactinomycin—kidney cancer	0.00107	0.00453	CcSEcCtD
Primidone—Connective tissue disorder—Sunitinib—kidney cancer	0.00107	0.00453	CcSEcCtD
Primidone—Musculoskeletal discomfort—Pazopanib—kidney cancer	0.00107	0.00452	CcSEcCtD
Primidone—Anaemia—Vinblastine—kidney cancer	0.00105	0.00445	CcSEcCtD
Primidone—Anaemia—Everolimus—kidney cancer	0.00105	0.00444	CcSEcCtD
Primidone—Somnolence—Pazopanib—kidney cancer	0.00104	0.00441	CcSEcCtD
Primidone—Vertigo—Vinblastine—kidney cancer	0.00102	0.00433	CcSEcCtD
Primidone—Depression—Vincristine—kidney cancer	0.00102	0.00433	CcSEcCtD
Primidone—Decreased appetite—Pazopanib—kidney cancer	0.00102	0.00431	CcSEcCtD
Primidone—Eye disorder—Sunitinib—kidney cancer	0.00102	0.0043	CcSEcCtD
Primidone—Gastrointestinal disorder—Pazopanib—kidney cancer	0.00101	0.00428	CcSEcCtD
Primidone—Fatigue—Pazopanib—kidney cancer	0.00101	0.00428	CcSEcCtD
Primidone—Ataxia—Paclitaxel—kidney cancer	0.000993	0.00421	CcSEcCtD
Primidone—Mental disorder—Sorafenib—kidney cancer	0.00099	0.00419	CcSEcCtD
Primidone—Malnutrition—Sorafenib—kidney cancer	0.000983	0.00417	CcSEcCtD
Primidone—Arthralgia—Everolimus—kidney cancer	0.000965	0.00409	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.000958	0.00406	CcSEcCtD
Primidone—Mental disorder—Sunitinib—kidney cancer	0.000952	0.00403	CcSEcCtD
Primidone—Malnutrition—Sunitinib—kidney cancer	0.000946	0.00401	CcSEcCtD
Primidone—Arthralgia—Erlotinib—kidney cancer	0.000931	0.00394	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.000924	0.00392	CcSEcCtD
Primidone—Blood disorder—Doxorubicin—kidney cancer	0.000921	0.0039	CcSEcCtD
Primidone—Anaemia—Sorafenib—kidney cancer	0.000909	0.00385	CcSEcCtD
Primidone—Nervous system disorder—Everolimus—kidney cancer	0.000907	0.00384	CcSEcCtD
Primidone—Agranulocytosis—Gemcitabine—kidney cancer	0.000907	0.00384	CcSEcCtD
Primidone—Connective tissue disorder—Vincristine—kidney cancer	0.000904	0.00383	CcSEcCtD
Primidone—Skin disorder—Everolimus—kidney cancer	0.000898	0.00381	CcSEcCtD
Primidone—Asthenia—Temsirolimus—kidney cancer	0.000892	0.00378	CcSEcCtD
Primidone—Anorexia—Vinblastine—kidney cancer	0.000885	0.00375	CcSEcCtD
Primidone—Anorexia—Everolimus—kidney cancer	0.000881	0.00373	CcSEcCtD
Primidone—Nervous system disorder—Erlotinib—kidney cancer	0.000875	0.00371	CcSEcCtD
Primidone—Anaemia—Sunitinib—kidney cancer	0.000875	0.00371	CcSEcCtD
Primidone—Skin disorder—Erlotinib—kidney cancer	0.000867	0.00367	CcSEcCtD
Primidone—Diplopia—Capecitabine—kidney cancer	0.000866	0.00367	CcSEcCtD
Primidone—Connective tissue disorder—Gemcitabine—kidney cancer	0.000857	0.00363	CcSEcCtD
Primidone—Anorexia—Erlotinib—kidney cancer	0.00085	0.0036	CcSEcCtD
Primidone—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000842	0.00357	CcSEcCtD
Primidone—Asthenia—Pazopanib—kidney cancer	0.00084	0.00356	CcSEcCtD
Primidone—Arthralgia—Sorafenib—kidney cancer	0.000837	0.00355	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000831	0.00352	CcSEcCtD
Primidone—Anaemia—Dactinomycin—kidney cancer	0.000828	0.00351	CcSEcCtD
Primidone—Somnolence—Everolimus—kidney cancer	0.000822	0.00348	CcSEcCtD
Primidone—Dizziness—Temsirolimus—kidney cancer	0.000822	0.00348	CcSEcCtD
Primidone—Ataxia—Capecitabine—kidney cancer	0.000815	0.00345	CcSEcCtD
Primidone—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000813	0.00344	CcSEcCtD
Primidone—Depression—Paclitaxel—kidney cancer	0.000811	0.00344	CcSEcCtD
Primidone—Decreased appetite—Vinblastine—kidney cancer	0.000807	0.00342	CcSEcCtD
Primidone—Arthralgia—Sunitinib—kidney cancer	0.000806	0.00341	CcSEcCtD
Primidone—Mental disorder—Vincristine—kidney cancer	0.000806	0.00341	CcSEcCtD
Primidone—Decreased appetite—Everolimus—kidney cancer	0.000804	0.00341	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.0008	0.00339	CcSEcCtD
Primidone—Gastrointestinal disorder—Everolimus—kidney cancer	0.000798	0.00338	CcSEcCtD
Primidone—Fatigue—Everolimus—kidney cancer	0.000797	0.00338	CcSEcCtD
Primidone—Vomiting—Temsirolimus—kidney cancer	0.00079	0.00335	CcSEcCtD
Primidone—Nervous system disorder—Sorafenib—kidney cancer	0.000787	0.00333	CcSEcCtD
Primidone—Rash—Temsirolimus—kidney cancer	0.000784	0.00332	CcSEcCtD
Primidone—Dermatitis—Temsirolimus—kidney cancer	0.000783	0.00332	CcSEcCtD
Primidone—Skin disorder—Sorafenib—kidney cancer	0.00078	0.0033	CcSEcCtD
Primidone—Headache—Temsirolimus—kidney cancer	0.000779	0.0033	CcSEcCtD
Primidone—Decreased appetite—Erlotinib—kidney cancer	0.000776	0.00329	CcSEcCtD
Primidone—Dizziness—Pazopanib—kidney cancer	0.000774	0.00328	CcSEcCtD
Primidone—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00077	0.00326	CcSEcCtD
Primidone—Fatigue—Erlotinib—kidney cancer	0.000769	0.00326	CcSEcCtD
Primidone—Anorexia—Sorafenib—kidney cancer	0.000765	0.00324	CcSEcCtD
Primidone—Nervous system disorder—Sunitinib—kidney cancer	0.000757	0.00321	CcSEcCtD
Primidone—Skin disorder—Sunitinib—kidney cancer	0.00075	0.00318	CcSEcCtD
Primidone—Vomiting—Pazopanib—kidney cancer	0.000745	0.00315	CcSEcCtD
Primidone—Anaemia—Vincristine—kidney cancer	0.00074	0.00313	CcSEcCtD
Primidone—Rash—Pazopanib—kidney cancer	0.000738	0.00313	CcSEcCtD
Primidone—Nausea—Temsirolimus—kidney cancer	0.000738	0.00313	CcSEcCtD
Primidone—Dermatitis—Pazopanib—kidney cancer	0.000738	0.00313	CcSEcCtD
Primidone—Anorexia—Sunitinib—kidney cancer	0.000736	0.00312	CcSEcCtD
Primidone—Headache—Pazopanib—kidney cancer	0.000734	0.00311	CcSEcCtD
Primidone—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000731	0.0031	CcSEcCtD
Primidone—Vertigo—Vincristine—kidney cancer	0.000719	0.00305	CcSEcCtD
Primidone—Connective tissue disorder—Paclitaxel—kidney cancer	0.000718	0.00304	CcSEcCtD
Primidone—Visual impairment—Paclitaxel—kidney cancer	0.000704	0.00298	CcSEcCtD
Primidone—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000704	0.00298	CcSEcCtD
Primidone—Anaemia—Gemcitabine—kidney cancer	0.000702	0.00297	CcSEcCtD
Primidone—Decreased appetite—Sorafenib—kidney cancer	0.000698	0.00296	CcSEcCtD
Primidone—Anorexia—Dactinomycin—kidney cancer	0.000697	0.00295	CcSEcCtD
Primidone—Nausea—Pazopanib—kidney cancer	0.000696	0.00295	CcSEcCtD
Primidone—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000693	0.00294	CcSEcCtD
Primidone—Fatigue—Sorafenib—kidney cancer	0.000692	0.00293	CcSEcCtD
Primidone—Eye disorder—Paclitaxel—kidney cancer	0.000682	0.00289	CcSEcCtD
Primidone—Decreased appetite—Sunitinib—kidney cancer	0.000671	0.00284	CcSEcCtD
Primidone—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000667	0.00282	CcSEcCtD
Primidone—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000666	0.00282	CcSEcCtD
Primidone—Asthenia—Vinblastine—kidney cancer	0.000666	0.00282	CcSEcCtD
Primidone—Fatigue—Sunitinib—kidney cancer	0.000666	0.00282	CcSEcCtD
Primidone—Depression—Capecitabine—kidney cancer	0.000666	0.00282	CcSEcCtD
Primidone—Asthenia—Everolimus—kidney cancer	0.000663	0.00281	CcSEcCtD
Primidone—Arthralgia—Gemcitabine—kidney cancer	0.000646	0.00274	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000642	0.00272	CcSEcCtD
Primidone—Nervous system disorder—Vincristine—kidney cancer	0.000641	0.00271	CcSEcCtD
Primidone—Asthenia—Erlotinib—kidney cancer	0.00064	0.00271	CcSEcCtD
Primidone—Mental disorder—Paclitaxel—kidney cancer	0.00064	0.00271	CcSEcCtD
Primidone—Malnutrition—Paclitaxel—kidney cancer	0.000636	0.00269	CcSEcCtD
Primidone—Decreased appetite—Dactinomycin—kidney cancer	0.000636	0.00269	CcSEcCtD
Primidone—Fatigue—Dactinomycin—kidney cancer	0.00063	0.00267	CcSEcCtD
Primidone—Agranulocytosis—Capecitabine—kidney cancer	0.000623	0.00264	CcSEcCtD
Primidone—Anorexia—Vincristine—kidney cancer	0.000623	0.00264	CcSEcCtD
Primidone—Dizziness—Vinblastine—kidney cancer	0.000614	0.0026	CcSEcCtD
Primidone—Dizziness—Everolimus—kidney cancer	0.000611	0.00259	CcSEcCtD
Primidone—Nervous system disorder—Gemcitabine—kidney cancer	0.000608	0.00257	CcSEcCtD
Primidone—Skin disorder—Gemcitabine—kidney cancer	0.000602	0.00255	CcSEcCtD
Primidone—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000595	0.00252	CcSEcCtD
Primidone—Anorexia—Gemcitabine—kidney cancer	0.000591	0.0025	CcSEcCtD
Primidone—Vomiting—Vinblastine—kidney cancer	0.00059	0.0025	CcSEcCtD
Primidone—Dizziness—Erlotinib—kidney cancer	0.00059	0.0025	CcSEcCtD
Primidone—Connective tissue disorder—Capecitabine—kidney cancer	0.000589	0.0025	CcSEcCtD
Primidone—Vomiting—Everolimus—kidney cancer	0.000588	0.00249	CcSEcCtD
Primidone—Anaemia—Paclitaxel—kidney cancer	0.000588	0.00249	CcSEcCtD
Primidone—Rash—Everolimus—kidney cancer	0.000583	0.00247	CcSEcCtD
Primidone—Dermatitis—Everolimus—kidney cancer	0.000582	0.00247	CcSEcCtD
Primidone—Headache—Vinblastine—kidney cancer	0.000581	0.00246	CcSEcCtD
Primidone—Headache—Everolimus—kidney cancer	0.000579	0.00245	CcSEcCtD
Primidone—Visual impairment—Capecitabine—kidney cancer	0.000578	0.00245	CcSEcCtD
Primidone—Asthenia—Sorafenib—kidney cancer	0.000576	0.00244	CcSEcCtD
Primidone—Vertigo—Paclitaxel—kidney cancer	0.000571	0.00242	CcSEcCtD
Primidone—Decreased appetite—Vincristine—kidney cancer	0.000568	0.00241	CcSEcCtD
Primidone—Vomiting—Erlotinib—kidney cancer	0.000567	0.0024	CcSEcCtD
Primidone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000565	0.00239	CcSEcCtD
Primidone—Gastrointestinal disorder—Vincristine—kidney cancer	0.000564	0.00239	CcSEcCtD
Primidone—Fatigue—Vincristine—kidney cancer	0.000563	0.00239	CcSEcCtD
Primidone—Rash—Erlotinib—kidney cancer	0.000563	0.00238	CcSEcCtD
Primidone—Dermatitis—Erlotinib—kidney cancer	0.000562	0.00238	CcSEcCtD
Primidone—Eye disorder—Capecitabine—kidney cancer	0.00056	0.00237	CcSEcCtD
Primidone—Headache—Erlotinib—kidney cancer	0.000559	0.00237	CcSEcCtD
Primidone—Diplopia—Doxorubicin—kidney cancer	0.000558	0.00237	CcSEcCtD
Primidone—Asthenia—Sunitinib—kidney cancer	0.000554	0.00235	CcSEcCtD
Primidone—Nausea—Vinblastine—kidney cancer	0.000551	0.00234	CcSEcCtD
Primidone—Somnolence—Gemcitabine—kidney cancer	0.000551	0.00233	CcSEcCtD
Primidone—Nausea—Everolimus—kidney cancer	0.000549	0.00233	CcSEcCtD
Primidone—Arthralgia—Paclitaxel—kidney cancer	0.000541	0.00229	CcSEcCtD
Primidone—Decreased appetite—Gemcitabine—kidney cancer	0.000539	0.00228	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000538	0.00228	CcSEcCtD
Primidone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000535	0.00227	CcSEcCtD
Primidone—Fatigue—Gemcitabine—kidney cancer	0.000534	0.00226	CcSEcCtD
Primidone—Dizziness—Sorafenib—kidney cancer	0.000531	0.00225	CcSEcCtD
Primidone—Nausea—Erlotinib—kidney cancer	0.00053	0.00225	CcSEcCtD
Primidone—Ataxia—Doxorubicin—kidney cancer	0.000525	0.00222	CcSEcCtD
Primidone—Mental disorder—Capecitabine—kidney cancer	0.000525	0.00222	CcSEcCtD
Primidone—Asthenia—Dactinomycin—kidney cancer	0.000525	0.00222	CcSEcCtD
Primidone—Malnutrition—Capecitabine—kidney cancer	0.000522	0.00221	CcSEcCtD
Primidone—Dizziness—Sunitinib—kidney cancer	0.000511	0.00216	CcSEcCtD
Primidone—Vomiting—Sorafenib—kidney cancer	0.00051	0.00216	CcSEcCtD
Primidone—Nervous system disorder—Paclitaxel—kidney cancer	0.000509	0.00216	CcSEcCtD
Primidone—Rash—Sorafenib—kidney cancer	0.000506	0.00214	CcSEcCtD
Primidone—Dermatitis—Sorafenib—kidney cancer	0.000506	0.00214	CcSEcCtD
Primidone—Skin disorder—Paclitaxel—kidney cancer	0.000504	0.00214	CcSEcCtD
Primidone—Headache—Sorafenib—kidney cancer	0.000503	0.00213	CcSEcCtD
Primidone—Anorexia—Paclitaxel—kidney cancer	0.000495	0.0021	CcSEcCtD
Primidone—Vomiting—Sunitinib—kidney cancer	0.000491	0.00208	CcSEcCtD
Primidone—Rash—Sunitinib—kidney cancer	0.000487	0.00206	CcSEcCtD
Primidone—Dermatitis—Sunitinib—kidney cancer	0.000487	0.00206	CcSEcCtD
Primidone—Headache—Sunitinib—kidney cancer	0.000484	0.00205	CcSEcCtD
Primidone—Anaemia—Capecitabine—kidney cancer	0.000482	0.00204	CcSEcCtD
Primidone—Nausea—Sorafenib—kidney cancer	0.000477	0.00202	CcSEcCtD
Primidone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000473	0.002	CcSEcCtD
Primidone—Vertigo—Capecitabine—kidney cancer	0.000469	0.00199	CcSEcCtD
Primidone—Asthenia—Vincristine—kidney cancer	0.000469	0.00199	CcSEcCtD
Primidone—Vomiting—Dactinomycin—kidney cancer	0.000465	0.00197	CcSEcCtD
Primidone—Somnolence—Paclitaxel—kidney cancer	0.000461	0.00195	CcSEcCtD
Primidone—Rash—Dactinomycin—kidney cancer	0.000461	0.00195	CcSEcCtD
Primidone—Nausea—Sunitinib—kidney cancer	0.000459	0.00194	CcSEcCtD
Primidone—Decreased appetite—Paclitaxel—kidney cancer	0.000451	0.00191	CcSEcCtD
Primidone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000448	0.0019	CcSEcCtD
Primidone—Fatigue—Paclitaxel—kidney cancer	0.000447	0.0019	CcSEcCtD
Primidone—Asthenia—Gemcitabine—kidney cancer	0.000445	0.00188	CcSEcCtD
Primidone—Arthralgia—Capecitabine—kidney cancer	0.000444	0.00188	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000441	0.00187	CcSEcCtD
Primidone—Nausea—Dactinomycin—kidney cancer	0.000434	0.00184	CcSEcCtD
Primidone—Dizziness—Vincristine—kidney cancer	0.000432	0.00183	CcSEcCtD
Primidone—Drowsiness—Doxorubicin—kidney cancer	0.00043	0.00182	CcSEcCtD
Primidone—Nervous system disorder—Capecitabine—kidney cancer	0.000418	0.00177	CcSEcCtD
Primidone—Vomiting—Vincristine—kidney cancer	0.000415	0.00176	CcSEcCtD
Primidone—Skin disorder—Capecitabine—kidney cancer	0.000414	0.00175	CcSEcCtD
Primidone—Rash—Vincristine—kidney cancer	0.000412	0.00174	CcSEcCtD
Primidone—Dermatitis—Vincristine—kidney cancer	0.000411	0.00174	CcSEcCtD
Primidone—Headache—Vincristine—kidney cancer	0.000409	0.00173	CcSEcCtD
Primidone—Anorexia—Capecitabine—kidney cancer	0.000406	0.00172	CcSEcCtD
Primidone—Agranulocytosis—Doxorubicin—kidney cancer	0.000402	0.0017	CcSEcCtD
Primidone—Vomiting—Gemcitabine—kidney cancer	0.000394	0.00167	CcSEcCtD
Primidone—Rash—Gemcitabine—kidney cancer	0.000391	0.00166	CcSEcCtD
Primidone—Dermatitis—Gemcitabine—kidney cancer	0.00039	0.00165	CcSEcCtD
Primidone—Headache—Gemcitabine—kidney cancer	0.000388	0.00164	CcSEcCtD
Primidone—Nausea—Vincristine—kidney cancer	0.000388	0.00164	CcSEcCtD
Primidone—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000388	0.00164	CcSEcCtD
Primidone—Connective tissue disorder—Doxorubicin—kidney cancer	0.00038	0.00161	CcSEcCtD
Primidone—Visual impairment—Doxorubicin—kidney cancer	0.000372	0.00158	CcSEcCtD
Primidone—Asthenia—Paclitaxel—kidney cancer	0.000372	0.00158	CcSEcCtD
Primidone—Decreased appetite—Capecitabine—kidney cancer	0.00037	0.00157	CcSEcCtD
Primidone—Nausea—Gemcitabine—kidney cancer	0.000368	0.00156	CcSEcCtD
Primidone—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000368	0.00156	CcSEcCtD
Primidone—Fatigue—Capecitabine—kidney cancer	0.000367	0.00156	CcSEcCtD
Primidone—Eye disorder—Doxorubicin—kidney cancer	0.000361	0.00153	CcSEcCtD
Primidone—Dizziness—Paclitaxel—kidney cancer	0.000343	0.00145	CcSEcCtD
Primidone—Mental disorder—Doxorubicin—kidney cancer	0.000338	0.00143	CcSEcCtD
Primidone—Malnutrition—Doxorubicin—kidney cancer	0.000336	0.00142	CcSEcCtD
Primidone—Vomiting—Paclitaxel—kidney cancer	0.00033	0.0014	CcSEcCtD
Primidone—Rash—Paclitaxel—kidney cancer	0.000327	0.00139	CcSEcCtD
Primidone—Dermatitis—Paclitaxel—kidney cancer	0.000327	0.00138	CcSEcCtD
Primidone—Headache—Paclitaxel—kidney cancer	0.000325	0.00138	CcSEcCtD
Primidone—Anaemia—Doxorubicin—kidney cancer	0.000311	0.00132	CcSEcCtD
Primidone—Nausea—Paclitaxel—kidney cancer	0.000308	0.00131	CcSEcCtD
Primidone—Asthenia—Capecitabine—kidney cancer	0.000305	0.00129	CcSEcCtD
Primidone—Vertigo—Doxorubicin—kidney cancer	0.000302	0.00128	CcSEcCtD
Primidone—Arthralgia—Doxorubicin—kidney cancer	0.000286	0.00121	CcSEcCtD
Primidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000284	0.0012	CcSEcCtD
Primidone—Dizziness—Capecitabine—kidney cancer	0.000282	0.00119	CcSEcCtD
Primidone—Vomiting—Capecitabine—kidney cancer	0.000271	0.00115	CcSEcCtD
Primidone—Nervous system disorder—Doxorubicin—kidney cancer	0.000269	0.00114	CcSEcCtD
Primidone—Rash—Capecitabine—kidney cancer	0.000268	0.00114	CcSEcCtD
Primidone—Dermatitis—Capecitabine—kidney cancer	0.000268	0.00114	CcSEcCtD
Primidone—Headache—Capecitabine—kidney cancer	0.000267	0.00113	CcSEcCtD
Primidone—Skin disorder—Doxorubicin—kidney cancer	0.000267	0.00113	CcSEcCtD
Primidone—Anorexia—Doxorubicin—kidney cancer	0.000262	0.00111	CcSEcCtD
Primidone—Nausea—Capecitabine—kidney cancer	0.000253	0.00107	CcSEcCtD
Primidone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.00025	0.00106	CcSEcCtD
Primidone—Somnolence—Doxorubicin—kidney cancer	0.000244	0.00103	CcSEcCtD
Primidone—Decreased appetite—Doxorubicin—kidney cancer	0.000239	0.00101	CcSEcCtD
Primidone—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000237	0.001	CcSEcCtD
Primidone—Fatigue—Doxorubicin—kidney cancer	0.000237	0.001	CcSEcCtD
Primidone—Asthenia—Doxorubicin—kidney cancer	0.000197	0.000834	CcSEcCtD
Primidone—Dizziness—Doxorubicin—kidney cancer	0.000181	0.000769	CcSEcCtD
Primidone—Vomiting—Doxorubicin—kidney cancer	0.000175	0.000739	CcSEcCtD
Primidone—Rash—Doxorubicin—kidney cancer	0.000173	0.000733	CcSEcCtD
Primidone—Dermatitis—Doxorubicin—kidney cancer	0.000173	0.000732	CcSEcCtD
Primidone—Headache—Doxorubicin—kidney cancer	0.000172	0.000728	CcSEcCtD
Primidone—Nausea—Doxorubicin—kidney cancer	0.000163	0.000691	CcSEcCtD
Primidone—CYP2C19—Metabolism—CCBL1—kidney cancer	3.38e-05	0.000425	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—MAPK1—kidney cancer	3.35e-05	0.000422	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.32e-05	0.000418	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CA2—kidney cancer	3.29e-05	0.000415	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ACY1—kidney cancer	3.29e-05	0.000415	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.28e-05	0.000414	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GLIPR1—kidney cancer	3.28e-05	0.000413	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PPAT—kidney cancer	3.28e-05	0.000413	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PDHB—kidney cancer	3.28e-05	0.000413	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.27e-05	0.000412	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—POMC—kidney cancer	3.26e-05	0.000411	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—MAPK1—kidney cancer	3.25e-05	0.00041	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.24e-05	0.000408	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ALAD—kidney cancer	3.21e-05	0.000404	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.21e-05	0.000404	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—MAPK1—kidney cancer	3.19e-05	0.000402	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—MAPK1—kidney cancer	3.14e-05	0.000395	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ST3GAL2—kidney cancer	3.13e-05	0.000395	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CCBL1—kidney cancer	3.08e-05	0.000388	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ALDH1A1—kidney cancer	3.06e-05	0.000386	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—MAPK1—kidney cancer	3.06e-05	0.000386	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.05e-05	0.000385	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—APRT—kidney cancer	3.05e-05	0.000384	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—FH—kidney cancer	3.05e-05	0.000384	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.05e-05	0.000384	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3e-05	0.000378	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.98e-05	0.000375	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PGK1—kidney cancer	2.94e-05	0.00037	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—SLC5A3—kidney cancer	2.94e-05	0.00037	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PPAT—kidney cancer	2.93e-05	0.000369	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GLIPR1—kidney cancer	2.93e-05	0.000369	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—RAF1—kidney cancer	2.91e-05	0.000366	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.89e-05	0.000364	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.89e-05	0.000364	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—LDHB—kidney cancer	2.88e-05	0.000363	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—RAF1—kidney cancer	2.87e-05	0.000361	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GPC3—kidney cancer	2.87e-05	0.000361	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.86e-05	0.000361	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.85e-05	0.000359	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.81e-05	0.000354	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PDHB—kidney cancer	2.8e-05	0.000353	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—POMC—kidney cancer	2.79e-05	0.000351	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CA2—kidney cancer	2.79e-05	0.000351	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.78e-05	0.000351	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—FH—kidney cancer	2.72e-05	0.000343	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—APRT—kidney cancer	2.72e-05	0.000343	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ALAD—kidney cancer	2.72e-05	0.000342	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—MAPK1—kidney cancer	2.68e-05	0.000337	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.67e-05	0.000336	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PPAT—kidney cancer	2.67e-05	0.000336	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.66e-05	0.000335	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ST3GAL2—kidney cancer	2.65e-05	0.000334	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.64e-05	0.000332	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CCBL1—kidney cancer	2.63e-05	0.000331	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.62e-05	0.000331	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.61e-05	0.000329	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ALDH1A1—kidney cancer	2.59e-05	0.000327	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GPC3—kidney cancer	2.56e-05	0.000322	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	2.55e-05	0.000321	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ACY1—kidney cancer	2.54e-05	0.00032	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	2.5e-05	0.000315	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CA9—kidney cancer	2.5e-05	0.000315	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CA2—kidney cancer	2.49e-05	0.000314	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PGK1—kidney cancer	2.49e-05	0.000313	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—SLC5A3—kidney cancer	2.49e-05	0.000313	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—FH—kidney cancer	2.48e-05	0.000313	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—APRT—kidney cancer	2.48e-05	0.000313	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.46e-05	0.00031	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—LDHB—kidney cancer	2.44e-05	0.000307	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ALAD—kidney cancer	2.43e-05	0.000306	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.43e-05	0.000306	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.4e-05	0.000302	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.38e-05	0.0003	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.37e-05	0.000298	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GPC3—kidney cancer	2.33e-05	0.000294	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.31e-05	0.000292	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GLIPR1—kidney cancer	2.28e-05	0.000287	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PPAT—kidney cancer	2.28e-05	0.000287	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CA2—kidney cancer	2.27e-05	0.000286	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.25e-05	0.000284	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.23e-05	0.000281	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—SLC5A3—kidney cancer	2.22e-05	0.00028	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PGK1—kidney cancer	2.22e-05	0.00028	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ALAD—kidney cancer	2.21e-05	0.000279	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—LDHB—kidney cancer	2.18e-05	0.000274	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PDHB—kidney cancer	2.16e-05	0.000272	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.16e-05	0.000272	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—POMC—kidney cancer	2.15e-05	0.000271	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CRABP1—kidney cancer	2.12e-05	0.000267	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—FH—kidney cancer	2.12e-05	0.000267	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—APRT—kidney cancer	2.12e-05	0.000267	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CA9—kidney cancer	2.11e-05	0.000266	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.11e-05	0.000266	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.1e-05	0.000264	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.07e-05	0.000261	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.07e-05	0.00026	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CCBL1—kidney cancer	2.03e-05	0.000256	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.02e-05	0.000255	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PGK1—kidney cancer	2.02e-05	0.000255	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GPC3—kidney cancer	1.99e-05	0.000251	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—LDHB—kidney cancer	1.98e-05	0.00025	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ITPR2—kidney cancer	1.97e-05	0.000249	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CA2—kidney cancer	1.94e-05	0.000244	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ALAD—kidney cancer	1.89e-05	0.000238	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CA9—kidney cancer	1.89e-05	0.000238	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.85e-05	0.000232	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.84e-05	0.000232	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.8e-05	0.000227	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ACHE—kidney cancer	1.8e-05	0.000227	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GSTT1—kidney cancer	1.8e-05	0.000227	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CRABP1—kidney cancer	1.8e-05	0.000226	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.76e-05	0.000222	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PPAT—kidney cancer	1.76e-05	0.000222	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.73e-05	0.000218	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PGK1—kidney cancer	1.73e-05	0.000218	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CA9—kidney cancer	1.72e-05	0.000217	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—SCARB1—kidney cancer	1.7e-05	0.000215	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—LDHB—kidney cancer	1.7e-05	0.000214	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PTGS1—kidney cancer	1.69e-05	0.000212	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.68e-05	0.000212	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ITPR2—kidney cancer	1.67e-05	0.00021	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PSMD7—kidney cancer	1.65e-05	0.000208	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—APRT—kidney cancer	1.64e-05	0.000206	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—FH—kidney cancer	1.64e-05	0.000206	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CRABP1—kidney cancer	1.6e-05	0.000202	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—BCHE—kidney cancer	1.57e-05	0.000198	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.55e-05	0.000195	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.54e-05	0.000194	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GPC3—kidney cancer	1.54e-05	0.000194	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ACHE—kidney cancer	1.52e-05	0.000192	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GSTT1—kidney cancer	1.52e-05	0.000192	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CA2—kidney cancer	1.5e-05	0.000189	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.5e-05	0.000188	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ITPR2—kidney cancer	1.49e-05	0.000188	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CA9—kidney cancer	1.47e-05	0.000185	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CRABP1—kidney cancer	1.46e-05	0.000184	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ALAD—kidney cancer	1.46e-05	0.000184	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—SCARB1—kidney cancer	1.44e-05	0.000182	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.44e-05	0.000181	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PTGS1—kidney cancer	1.43e-05	0.00018	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.42e-05	0.000179	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PSMD7—kidney cancer	1.4e-05	0.000176	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.39e-05	0.000175	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.38e-05	0.000173	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GSTT1—kidney cancer	1.36e-05	0.000171	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ACHE—kidney cancer	1.36e-05	0.000171	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ITPR2—kidney cancer	1.36e-05	0.000171	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.33e-05	0.000168	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PGK1—kidney cancer	1.33e-05	0.000168	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—BCHE—kidney cancer	1.33e-05	0.000167	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.31e-05	0.000165	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—LDHB—kidney cancer	1.31e-05	0.000165	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—SCARB1—kidney cancer	1.29e-05	0.000162	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PTGS1—kidney cancer	1.27e-05	0.000161	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.27e-05	0.00016	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.25e-05	0.000158	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CRABP1—kidney cancer	1.25e-05	0.000157	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PSMD7—kidney cancer	1.25e-05	0.000157	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GSTP1—kidney cancer	1.25e-05	0.000157	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GSTT1—kidney cancer	1.24e-05	0.000156	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ACHE—kidney cancer	1.24e-05	0.000156	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.23e-05	0.000155	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—BCHE—kidney cancer	1.18e-05	0.000149	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ABCB1—kidney cancer	1.18e-05	0.000149	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—SCARB1—kidney cancer	1.17e-05	0.000148	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.17e-05	0.000147	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ITPR2—kidney cancer	1.16e-05	0.000146	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PTGS1—kidney cancer	1.16e-05	0.000146	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—GSTM1—kidney cancer	1.15e-05	0.000144	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PSMD7—kidney cancer	1.14e-05	0.000144	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CA9—kidney cancer	1.13e-05	0.000143	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.13e-05	0.000142	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.1e-05	0.000138	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.09e-05	0.000137	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—BCHE—kidney cancer	1.08e-05	0.000136	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.07e-05	0.000135	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.07e-05	0.000135	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.07e-05	0.000134	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ACHE—kidney cancer	1.06e-05	0.000134	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GSTT1—kidney cancer	1.06e-05	0.000134	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GSTP1—kidney cancer	1.06e-05	0.000133	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.03e-05	0.00013	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—SCARB1—kidney cancer	1e-05	0.000126	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1e-05	0.000126	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ABCB1—kidney cancer	1e-05	0.000126	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PTGS1—kidney cancer	9.93e-06	0.000125	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PSMD7—kidney cancer	9.74e-06	0.000123	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—GSTM1—kidney cancer	9.71e-06	0.000122	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CRABP1—kidney cancer	9.65e-06	0.000122	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.56e-06	0.00012	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GSTP1—kidney cancer	9.43e-06	0.000119	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—BCHE—kidney cancer	9.23e-06	0.000116	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CYP1A1—kidney cancer	9.2e-06	0.000116	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—SLC5A5—kidney cancer	9.12e-06	0.000115	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ITPR2—kidney cancer	8.97e-06	0.000113	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ABCB1—kidney cancer	8.92e-06	0.000112	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—SLC2A1—kidney cancer	8.81e-06	0.000111	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.72e-06	0.00011	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—GSTM1—kidney cancer	8.66e-06	0.000109	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GSTP1—kidney cancer	8.6e-06	0.000108	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.55e-06	0.000108	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CYP1A1—kidney cancer	8.21e-06	0.000103	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTT1—kidney cancer	8.18e-06	0.000103	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ACHE—kidney cancer	8.18e-06	0.000103	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ABCB1—kidney cancer	8.14e-06	0.000103	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—POMC—kidney cancer	8.1e-06	0.000102	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—GSTM1—kidney cancer	7.9e-06	9.95e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SCARB1—kidney cancer	7.74e-06	9.75e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PTGS1—kidney cancer	7.66e-06	9.65e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.56e-06	9.52e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PSMD7—kidney cancer	7.52e-06	9.47e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CYP1A1—kidney cancer	7.49e-06	9.43e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.45e-06	9.39e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GSTP1—kidney cancer	7.35e-06	9.25e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—BCHE—kidney cancer	7.13e-06	8.98e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.04e-06	8.87e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ABCB1—kidney cancer	6.95e-06	8.76e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—POMC—kidney cancer	6.86e-06	8.64e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SLC2A1—kidney cancer	6.8e-06	8.56e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—GSTM1—kidney cancer	6.75e-06	8.5e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.75e-06	8.5e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PTGS2—kidney cancer	6.46e-06	8.14e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CYP1A1—kidney cancer	6.4e-06	8.06e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.15e-06	7.75e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—POMC—kidney cancer	6.12e-06	7.71e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTP1—kidney cancer	5.67e-06	7.14e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PTEN—kidney cancer	5.64e-06	7.1e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—POMC—kidney cancer	5.58e-06	7.03e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PTGS2—kidney cancer	5.47e-06	6.89e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ABCB1—kidney cancer	5.37e-06	6.76e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.26e-06	6.62e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—GSTM1—kidney cancer	5.21e-06	6.56e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.94e-06	6.22e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PTGS2—kidney cancer	4.88e-06	6.15e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PTEN—kidney cancer	4.77e-06	6.01e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—POMC—kidney cancer	4.77e-06	6.01e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PTGS2—kidney cancer	4.45e-06	5.61e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PTEN—kidney cancer	4.26e-06	5.37e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—PIK3CA—kidney cancer	3.98e-06	5.01e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PTEN—kidney cancer	3.88e-06	4.89e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PTGS2—kidney cancer	3.81e-06	4.79e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—POMC—kidney cancer	3.68e-06	4.64e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—PIK3CA—kidney cancer	3.37e-06	4.24e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PTEN—kidney cancer	3.32e-06	4.18e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—PIK3CA—kidney cancer	3e-06	3.79e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PTGS2—kidney cancer	2.94e-06	3.7e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.74e-06	3.45e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PTEN—kidney cancer	2.56e-06	3.23e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.34e-06	2.95e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.81e-06	2.28e-05	CbGpPWpGaD
